by Daniel M. Albert
|
| List Price: | $119.95 |
| Amazon Price: | $108.00 & eligible for FREE Super Saver Shipping on orders over $25. |
| You Save: | $11.95 (10%) |
| Average Rating: |  |
| Lowest New Price: | $107.97 |
| Availablitiy: | Usually ships in 24 hours |
|
 |
|
Product Description
The development of ophthalmology to its present level of sophisticated practice is an extraordinary story of research, experiment, and achievement. Dates in Ophthalmology: A Chronological Record of Progress in Ophthalmology over the Last Millennium charts the progress of that achievement over the last millennium, highlighting and describing the key dates of advancement. It presents a concise listing of the chief personages, periods, publications, and events in the history of ophthalmology from ancient times to the present. The book demonstrates how ideas, discoveries, and technologies cross borders and oceans. It illustrates the interplay of subspecialties, the changing pre-eminence of countries and cities, and the explosions of creativity and generations of dormancy in various areas. The author highlights the numerous and diverse events and people responsible for shaping this specialty. There are many ways of looking at history: from the standpoint of the lives of major figures, of society and impact, of subspecialties, of countries, of institutions, and of books. By presenting its information chronologically, Dates in Ophthalmology explores the how these areas intersect, influence, and impact each other.
Average Customer Review:
8 of 8 people found the following review helpful:
Eye Cancer: Past and the Future, 2008-05-09
There are 1,750 entries in "Dates in Ophthalmology," a "chronological record of progress of ophthalmology over the last millennium," by noted ocular pathologist, Dr. Daniel Albert.
Of those, only 15 deal with ocular melanoma, an eye cancer also known as uveal melanoma, choroidal melanoma, eye melanoma, intraocular melanoma and ciliary body melanoma.
That works out to about 1% of the total entries, which, oddly enough, mirrors the total number of people diagnosed with this cancer each year as compared to all other cancers. In both the historical and personal experience, eye cancer is a rare disease.
The majority of the chronology briefly and elegantly describes 1,000 years worth of discoveries into cataracts, eye design and structure, instruments and techniques, trauma and infections. It's clear that even rudimentary research executed by primitive means led to sustained improvements in patient eye health.
Except, that is, for ocular melanoma, the cause of and cure for which continues to elude today's clinicians and patients.
It's fitting then, that Dr. Albert gives ocular melanoma the very last entry in his compilation. In 2002, the National Eye Institute's Collaborative Ocular Melanoma Study (COMS), which he worked on from 1985-2003, and where he led the Pathology Center, proved that the modern-day treatment of bracytherapy had the same survival rates as the ancient therapy of enucleation (eye removal).
In closing like this, even Albert, a dedicated champion of ocular research, recognizes that ocular melanoma remains a challenge to visual science. Let's hope that the next 1,000-year ophthalmic chronology opens on a better note.
Price is accurate as of the date/time indicated. Prices and product availability are subject to change. Any price displayed on the Amazon website at the time of purchase will govern the sale of this product.
|
Store Categories
|